Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets

被引:42
作者
Bech, P. [1 ]
Fava, M. [2 ]
Trivedi, M. H. [3 ]
Wisniewski, S. R. [4 ]
Rush, A. J. [5 ]
机构
[1] Univ Copenhagen, Psychiat Res Unit, Frederiksborg Gen Hosp, DK-3400 Hillerod, Denmark
[2] Harvard Univ, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA
[3] Univ Texas, SW Med Sch, Dallas, TX USA
[4] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA
[5] Duke NUS, Singapore, Singapore
基金
美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词
Hamilton depression scale; Inventory of Depressive Symptomatology; Principal component analysis; Item response theory analysis; SEQUENCED TREATMENT ALTERNATIVES; RATIONALE; ILLNESS;
D O I
10.1016/j.jad.2011.03.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The factor structure and dimensionality of the HAM-D-17 and the IDS-C-30 are as yet uncertain, because psychometric analyses of these scales have been performed without a clear separation between factor structure profile and dimensionality (total scores being a sufficient statistic). Methods: The first treatment step (Level 1) in the STAR*D study provided a dataset of 4041 outpatients with DSM-IV nonpsychotic major depression. The HAM-D-17 and IDS-C-30 were evaluated by principal component analysis (PCA) without rotation. Mokken analysis tested the unidimensionality of the IDS-C-6, which corresponds to the unidimensional HAM-D-6. Results: For both the HAM-D-17 and IDS-C-30, PCA identified a bi-directional factor contrasting the depressive symptoms versus the neurovegetative symptoms. The HAM-D-6 and the corresponding IDS-C-6 symptoms all emerged in the depression factor. Both the HAM-D-6 and IDS-C-6 were found to be unidimensional scales, i.e., their total scores are each a sufficient statistic for the measurement of depressive states. Limitations: STAR*D used only one medication in Level 1. Conclusions: The unidimensional HAM-D-6 and IDS-C-6 should be used when evaluating the pure clinical effect of antidepressive treatment, whereas the multidimensional HAM-D-17 and IDS-C-30 should be considered when selecting antidepressant treatment. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:396 / 400
页数:5
相关论文
共 29 条
  • [21] OBJECTIVE TESTS AS INSTRUMENTS OF PSYCHOLOGICAL THEORY
    LOEVINGER, J
    [J]. PSYCHOLOGICAL REPORTS, 1957, 3 (04) : 635 - 694
  • [22] Pichot P., 1981, Psychiatria Fennica, V13, P183
  • [23] RASCH G, 1953, NORDISK PSYKOLOGIS M, V3, P65
  • [24] RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P884
  • [25] Roth M, 2001, J AFFECT DISORDERS, V64, P1
  • [26] Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
    Rush, AJ
    Fava, M
    Wisniewski, SR
    Lavori, PW
    Trivedi, MH
    Sackeim, HA
    Thase, ME
    Nierenberg, AA
    Quitkin, FM
    Kashner, TM
    Kupfer, DJ
    Rosenbaum, JF
    Alpert, J
    Stewart, JW
    McGrath, PJ
    Biggs, MM
    Shores-Wilson, K
    Lebowitz, BD
    Ritz, L
    Niederehe, G
    [J]. CONTROLLED CLINICAL TRIALS, 2004, 25 (01): : 119 - 142
  • [27] RUSH AJ, 1986, PSYCHIAT RES, V18, P65
  • [28] Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
    Uher, Rudolf
    Maier, Wolfgang
    Hauser, Joanna
    Marusic, Andrej
    Schmael, Christine
    Mors, Ole
    Henigsberg, Neven
    Souery, Daniel
    Placentino, Anna
    Rietschel, Marcella
    Zobel, Astrid
    Dmitrzak-Weglarz, Monika
    Petrovic, Ana
    Jorgensen, Lisbeth
    Kalember, Petra
    Giovannini, Caterina
    Barreto, Mara
    Elkin, Amanda
    Landau, Sabine
    Farmer, Anne
    Aitchison, Katherine J.
    McGuffin, Peter
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (03) : 252 - 259
  • [29] Willner P., 2002, Biological Psychiatry, P25, DOI [10.1002/0470854871.chii, DOI 10.1002/0470854871.CHII]